Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.
You're using version {0} of the web browser {1}. This means that the content or functionality of our website may be limited or unavailable. We recommend that you upgrade your browser to optimise your experience of our website.
Regulatory and Medical Device Development Strategy for Ambusol’s Glioblastoma Treatment
| Reference number | 2026-00561 |
| Coordinator | Ambusol AB (publ) |
| Funding from Vinnova | SEK 200 000 |
| Project duration | May 2026 - September 2026 |
| Status | Ongoing |
| Venture | Medtech4Health: Competence Enhancement in SME |
| Call | Medtech4Health: Competence Enhancement in Small Businesses, spring 2026 |
som bifogat
som bifogat
som bifogat
The project description has been provided by the project members themselves and the text has not been looked at by our editors.
Last updated 1 June 2026
Reference number 2026-00561
